Comments
Loading...

Adaptimmune Therapeutics

ADAPNASDAQ
Logo brought to you by Benzinga Data
$1.02
-0.01-1.44%
Last update: 10:10 AM
15 minutes delayed

Adaptimmune Therapeutics (NASDAQ:ADAP) Stock Quotes, Forecast and News Summary

Adaptimmune Therapeutics Stock (NASDAQ: ADAP) stock price, news, charts, stock research, profile.

Open$1.03
Close-
Volume / Avg.241.00K / 1.83M
Day Range$1.03 - $1.06
52 Wk Range0.42 - 2.05
Market Cap$262.14M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
40
Short Interest
4%
Days to Cover4.97

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Jul
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.0
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Adaptimmune Therapeutics Plc
Sector
Health Care
Industry
Biotechnology
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ADAP
ZURA

FAQ

Q

How do I buy Adaptimmune Therapeutics (ADAP) stock?

A

You can purchase shares of Adaptimmune Therapeutics (NASDAQ:ADAP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Adaptimmune Therapeutics (ADAP) competitors?

Q

What is the forecast, or price target, for Adaptimmune Therapeutics (ADAP) stock?

A

Adaptimmune Therapeutics has a consensus price target of $4.51.

Q

What is the current price for Adaptimmune Therapeutics (ADAP)?

A

The stock price for Adaptimmune Therapeutics (NASDAQ: ADAP) is $1.04 last updated September 19, 2024 at 9:25 AM EDT.

Q

Does Adaptimmune Therapeutics (ADAP) pay a dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?

A

Adaptimmune Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Q

Is Adaptimmune Therapeutics (ADAP) going to split?

A

There is no upcoming split for Adaptimmune Therapeutics.

Q

What sector and industry does Adaptimmune Therapeutics (ADAP) operate in?

A

Adaptimmune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch